biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)
Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –
biote operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
biote's operating cash flow for the twelve months ending Jun 30, 2026 was $24.37M, down 41.3% year over year. For fiscal 2025 it was $35.19M, down 22.2% from the year before. The highest annual figure on record is $45.24M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.19M | -22.2% |
| FY2024 | Dec 31, 2024 | $45.24M | +68.3% |
| FY2023 | Dec 31, 2023 | $26.88M | – |
| FY2022 | Dec 31, 2022 | -$9.16M | -127.2% |
| FY2021 | Dec 31, 2021 | $33.72M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.18M | -116.6% |
| Q1 FY2026 | Mar 31, 2026 | $3.90M | -39.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.57M | -38.8% |
| Q3 FY2025 | Sep 30, 2025 | $14.07M | -9.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.09M | -28.8% |
| Q1 FY2025 | Mar 31, 2025 | $6.47M | -12.3% |
| Q4 FY2024 | Dec 31, 2024 | $12.37M | +77.8% |
| Q3 FY2024 | Sep 30, 2024 | $15.56M | +9622.5% |
| Q2 FY2024 | Jun 30, 2024 | $9.95M | +46.8% |
| Q1 FY2024 | Mar 31, 2024 | $7.37M | -43.3% |
| Q4 FY2023 | Dec 31, 2023 | $6.96M | +15.0% |
| Q3 FY2023 | Sep 30, 2023 | $160.00K | -97.5% |
| Q2 FY2023 | Jun 30, 2023 | $6.78M | – |
| Q1 FY2023 | Mar 31, 2023 | $12.99M | +86.4% |
| Q4 FY2022 | Dec 31, 2022 | $6.05M | -40.0% |
| Q3 FY2022 | Sep 30, 2022 | $6.39M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | -$28.57M | -259.2% |
| Q1 FY2022 | Mar 31, 2022 | $6.97M | – |
| Q4 FY2021 | Dec 31, 2021 | $10.08M | – |
| Q3 FY2021 | Sep 30, 2021 | $6.32M | – |
| Q2 FY2021 | Jun 30, 2021 | $17.94M | – |
| Q1 FY2021 | Mar 31, 2021 | -$627.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
See a number that looks wrong?